BIOMAT Database Logo BIOMAT Database Logo

Current drug therapy of arterial hypertension. 1967

A S Godbole

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents

Related Publications

A S Godbole
Current drug targets and future therapy of pulmonary arterial hypertension.
January 2007, Current medicinal chemistry,
A S Godbole
[Drug therapy of arterial hypertension].
January 1987, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
A S Godbole
[Drug therapy of arterial hypertension].
June 1972, Therapeutische Umschau. Revue therapeutique,
A S Godbole
[Drug therapy of arterial hypertension].
December 1999, Der Internist,
A S Godbole
[Drug therapy of arterial hypertension].
April 1967, Therapie der Gegenwart,
A S Godbole
[Drug therapy of arterial hypertension].
May 1969, Therapeutique (La Semaine des hopitaux),
A S Godbole
[Drug therapy of arterial hypertension].
October 1961, Therapie der Gegenwart,
A S Godbole
[Arterial hypertension: current principles of therapy].
January 2003, Klinicheskaia meditsina,
A S Godbole
[Drug therapy for arterial hypertension].
February 1982, Soins; la revue de reference infirmiere,
A S Godbole
[Drug therapy for arterial hypertension].
January 1958, Revue medicale de Liege,
Copied contents to your clipboard!